Detalle Publicación

Manejo clínico de los eventos adversos cutáneos en pacientes tratados con quimioterapia: consenso nacional de la Academia Española de Dermatología y Venereología y de la Sociedad Española de Oncología Médica

Autores: Sanmartin, O.; Beato, C.; Suh-Oh, H. J.; Aragon, I. ; España Alonso, Agustín; Majem, M. ; Segura, S.; Gurpide Ayarra, Luis Alfonso; Botella, R. (Autor de correspondencia); Gravalos, C.
ISSN: 0001-7310
Volumen: 110
Número: 6
Páginas: 448 - 459
Fecha de publicación: 2019
Although the arrival of new chemotherapy drugs and combinations has brought progress in terms of cancer patient survival, they entail many adverse effects that can compromise treatment, and hence prognosis, of the disease. Cytostatic agents can cause dermatological toxicity, among other side effects. The most familiar adverse effect of chemotherapy is alopecia. Although not serious, this changes the outward appearance of cancer patients. Other adverse effects include hypersensitivity and photosensitivity reactions, hand-foot syndrome, epidermal necrolysis, recall reactions, scleroderma-like reactions, Raynaud's phenomenon, eccrine squamous syringometaplasia, neutrophilic eccrine hidradenitis, nail abnormalities, pigmentation changes and extravasation injuries. Onset of these adverse effects often causes ose reduction and/or delayed treatment, which can affect patient survival and quality of life. It is therefore important to prevent their occurrence and treat them promptly, which requires cooperation between medical oncologists and dermatologists. This article reviews chemotherapy ssociated dermatological toxicity, along with its diagnosis and therapeuticmanagement. (C) 2019 AEDV. Published by Elsevier Espana, S.L.U. All rights reserved.